Effects of long-term finasteride treatment on prostate cancer morphology and clinical outcome

Urology

Volumn 66, Issue 5, 2005, Pages 930-934

  Rubin, Mark A ^b   Allory, Yves ^b   Molinié, Vincent ^b   Leroy, Xavier ^b   Faucon, Hugo ^b   Vacherot, Francis ^b   Huang, Wei ^b   Kuten, Adam ^b   Salomon, Laurent ^b   Rebillard, Xavier ^b   Cussenot, Olivier ^b   Abbou, Claude ^b   De La Taille, Alexandre ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FINASTERIDE; GONADORELIN AGONIST;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER PATIENT; CELL VACUOLE; CONTROLLED STUDY; GLEASON SCORE; HORMONAL THERAPY; HORMONE ACTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MORPHOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

ADULT; AGED; AGED, 80 AND OVER; FINASTERIDE; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 27744578220     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2005.07.036     Document Type: Article

References (12)

1. I.M. Thompson, P.J. Goodman, C.M. Tangen The influence of finasteride on the development of prostate cancer N Engl J Med 349 2003 215 224
2. M.A. Rubin, P.W. Kantoff Prevention of prostate cancer with finasteride N Engl J Med 349 2003 1569 1572
3. P.T. Scardino The prevention of prostate cancer - the dilemma continues N Engl J Med 349 2003 297 299
4. M.A. Rubin, P.W. Kantoff Effect of finasteride on risk of prostate cancer how little we really know J Cell Biochem 91 2004 478 482
5. D.G. Bostwick, J. Qian, F. Civantos Does finasteride alter the pathology of the prostate and cancer grading? Clin Prostate Cancer 4 2004 228 235
6. D.G. Bostwick, D. Ramnani, L. Cheng Treatment changes in prostatic hyperplasia and cancer, including androgen deprivation therapy and radiotherapy Urol Clin North Am 26 1999 465 479
7. A. de la Taille, P. Antiphon, L. Salomon Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate Urology 61 2003 1181 1186
8. L. Salomon, A.G. Anastasiadis, O. Levrel Location of positive surgical margins after retropubic, perineal, and laparoscopic radical prostatectomy for organ-confined prostate cancer Urology 61 2003 386 390
9. B.S. Carver, M.W. Kattan, P.T. Scardino Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy BJU Int 95 2005 509 512
10. J.M. Unger, I.M. Thompson Jr, M. LeBlanc Estimated impact of the Prostate Cancer Prevention Trial on population mortality Cancer 103 2005 1375 1380
11. F. Civantos, M.S. Soloway, J.E. Pinto Histopathological effects of androgen deprivation in prostatic cancer Semin Urol Oncol 14 1996 22 31
12. X.J. Yang, K. Lecksell, K. Short Proscar Long-Term Efficacy and Safety Study (PLESS) Study Group Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? Urology 53 1999 696 700